Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

Recruiting now

Conditions studied: Prostate Cancer

In brief

Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment

Key facts

Study ID

NCT05295407

Run by

Endeavor Health

People needed

1000

Starts

2021-12-13

Expected to finish

2027-12-13

Last updated by the study team

2026-02-27

Who can join

Age: 40 and older, up to 69. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Consecutive patients undergoing prostate biopsy for detection of prostate cancer
• Aged 40 to 69 years
• Four ethnicity groups (Caucasian, African Americans, East Asians, Latinos)
• PSA between 2.5-10 ng/mL

You may not qualify if…

• Previous diagnosis of prostate cancer.
• Ethnicity outside the inclusion criterion (including mixed ethnicity).
• Any prior PSA test result outside the range of inclusion criterion.

Where it is running

• NorthShore University HealthSystem — Evanston, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.